Vall d'Hebron participates in a clinical trial to evaluate the efficacy and safety of low-dose selinexor in patients with severe COVID-19
Comparteix aquest contingut
Related professionals
Sra. Carmen
Ferrer Barbera
Ferrer Barbera
Sra. Carmen
Ferrer Barbera
Ferrer Barbera
Dr. Vicenç
Falcó Ferrer
Falcó Ferrer
Dr. Vicenç
Falcó Ferrer
Falcó Ferrer
Dr. Israel
Molina Romero
Molina Romero
Dr. Israel
Molina Romero
Molina Romero
Lead Researcher
Dr. Adrián
Sánchez Montalvá
Sánchez Montalvá
Dr. Adrián
Sánchez Montalvá
Sánchez Montalvá
Researcher
Dr. Adrià
Curran Fàbregas
Curran Fàbregas
Dr. Adrià
Curran Fàbregas
Curran Fàbregas
Researcher
Dr. Fernando
Salvador Vélez
Salvador Vélez
Dr. Fernando
Salvador Vélez
Salvador Vélez
Researcher
Dr. Pau
Bosch Nicolau
Bosch Nicolau
Dr. Pau
Bosch Nicolau
Bosch Nicolau
Sra. Desideria
Martinez Rascon
Martinez Rascon
Sra. Desideria
Martinez Rascon
Martinez Rascon